PER Resource Center: Integrating Novel Approaches in TNBC – New Avenues for TROP2-Targeting ADCs and Beyond

Summary: Triple-negative breast cancer (TNBC) can be tough to treat, but scientists have a new target called TROP2. TROP2 shows up a lot on cancer cells but not much on healthy ones. Doctors and nurses are learning how to use special medicines called ADCs to deliver strong chemotherapy straight to these cancer cells, acting like smart bombs. A new online course helps healthcare workers learn how to use these medicines, manage side effects, and give patients the best care possible.

For more details, see rssapp-patientcareonline-com at gotoper.com/courses/per-resource-center-integrating-novel-approaches-in-tnbc-new-avenues-for-trop2-targeting-adcs-and-beyond-nursing?utm_source=patientcareonline&utm_medium=homePage&utm_campaign=cmeDeck (opens in new tab)